CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival

Purpose Primary purpose was to assess changes of bone mineral density (BMD) in diffuse large B cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone R-CHOP (like) chemotherapy regimen. Secondary purposes were to assess other body compositio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiologia medica 2023-12, Vol.128 (12), p.1497-1507
Hauptverfasser:	Pirosa, Maria Cristina, Esposito, Fabiana, Raia, Giorgio, Chianca, Vito, Cozzi, Andrea, Ruinelli, Lorenzo, Ceriani, Luca, Zucca, Emanuele, Del Grande, Filippo, Rizzo, Stefania
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Murine-Derived - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Body composition Body size Computed Tomography Diagnostic Radiology Disease-Free Survival Doxorubicin Doxorubicin - therapeutic use Humans Imaging Interventional Radiology Lymphoma Lymphoma, Large B-Cell, Diffuse - diagnostic imaging Lymphoma, Large B-Cell, Diffuse - drug therapy Mean Medicine Medicine & Public Health Muscles Musculoskeletal system Neuroradiology Normal distribution Positron Emission Tomography Computed Tomography Radiology Rank tests Rituximab - therapeutic use Statistical analysis Subgroups Survival Treatment Outcome Ultrasound Vincristine - adverse effects Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!